GlassScriptPhysician profile
Aileen Alvarez
NPI 1902357262
$358.07
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $111 · 2022: $68.15 · 2023: $179.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $179.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $178.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $94.35 | 2021 | |
| Janssen Biotech, INC. | $63.42 | 2023 | Tecvayli, Rybrevant |
| Incyte Corporation | $51.62 | 2022-2023 | Monjuvi, Pemazyre |
| Novartis Pharmaceuticals Corporation | $49.79 | 2022-2023 | |
| Seagen INC. | $37.04 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $24.80 | 2023 | |
| Genentech USA, INC. | $21.00 | 2023 | Lunsumio |
| Amgen INC. | $16.05 | 2023 | Blincyto, Kyprolis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aileen Alvarez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.